Company Overview: NephroGenex

Industry News

16 Feb

NephroGenex to Host Conference Call and Webcast on Fourth Quarter and Full Year 2015 Financial Results on Thursday, February 25, 2016

RALEIGH, N.C.–(BUSINESS WIRE)– NephroGenex, Inc. (Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, will report its fourth quarter and full year 2015 financial results on Wednesday, February 24 after the U.S. financial markets close. The Company will host a conference call and webcast...

Read more

6 Jan

NephroGenex to Participate in Two Healthcare Conferences in January

RALEIGH, N.C.–(BUSINESS WIRE)–  NephroGenex, Inc. (Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced that CEO and President Pierre Legault will present a corporate overview of the Company at two upcoming healthcare conferences in January. The Company will also meet with members...

Read more

5 Jan

NephroGenex Announces Formation of Scientific Advisory Board

RALEIGH, N.C.–(BUSINESS WIRE)– NephroGenex, Inc. (Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced the appointment of leading experts in nephrology to its newly formed Scientific Advisory Board (SAB). The SAB will serve as a strategic resource to NephroGenex as it continues...

Read more

11 Nov

NephroGenex Reports Third Quarter 2015 Financial Results

Conference call and webcast to be held Thursday, November 12, 2015 at 8:30 a.m. EST RALEIGH, N.C.–(BUSINESS WIRE)– NephroGenex, Inc. (Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today reported financial results and business highlights for the third quarter ended September 30, 2015. “During...

Read more

30 Sep

NephroGenex to Present at the 2015 Aegis Growth Conference

RALEIGH, N.C.–(BUSINESS WIRE)– NephroGenex, Inc. (Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced that Chief Executive Officer Pierre Legault will present a corporate overview of the Company and meet with investors at the 2015 Aegis Growth Conference in Las Vegas. The...

Read more

31 Aug

NephroGenex To Participate In Two Healthcare Conferences In September

RALEIGH, N.C.–(BUSINESS WIRE)— NephroGenex, Inc. (Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced that Chief Executive Officer Pierre Legault and other members of management will present a corporate overview of the Company and meet with investors at the Rodman & Renshaw...

Read more

12 Aug

NephroGenex Reports Second Quarter 2015 Financial Results

RALEIGH, N.C.–(BUSINESS WIRE)– NephroGenex, Inc. (Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today reported financial results and business highlights for the second quarter ended June 30, 2015. “During the second quarter of 2015, we made substantial gains in advancing our Phase 3...

Read more

27 Jul

NephroGenex Appoints Dr. Jaikrishna Patel as Chief Medical Officer

NephroGenex, Inc. (Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced the appointment of Dr. Jaikrishna Patel to the position of Chief Medical Officer. Dr. Patel will help guide the Company’s Phase 3 PIONEER program with oral Pyridorin® for the treatment of...

Read more

Page 1 of 212

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address